182 related articles for article (PubMed ID: 24367708)
1. A qualitative assessment of the content validity of the ICECAP-A and EQ-5D-5L and their appropriateness for use in health research.
Keeley T; Al-Janabi H; Lorgelly P; Coast J
PLoS One; 2013; 8(12):e85287. PubMed ID: 24367708
[TBL] [Abstract][Full Text] [Related]
2. 'The ICECAP-SCM tells you more about what I'm going through': A think-aloud study measuring quality of life among patients receiving supportive and palliative care.
Bailey C; Kinghorn P; Orlando R; Armour K; Perry R; Jones L; Coast J
Palliat Med; 2016 Jul; 30(7):642-52. PubMed ID: 26819326
[TBL] [Abstract][Full Text] [Related]
3. Response process validity of three patient reported outcome measures for people requiring kidney care: a think-aloud study using the EQ-5D-5L, ICECAP-A and ICECAP-O.
Mitchell PM; Caskey FJ; Scott J; Sanghera S; Coast J
BMJ Open; 2020 May; 10(5):e034569. PubMed ID: 32414822
[TBL] [Abstract][Full Text] [Related]
4. Is the EQ-5D fit for purpose in asthma? Acceptability and content validity from the patient perspective.
Whalley D; Globe G; Crawford R; Doward L; Tafesse E; Brazier J; Price D
Health Qual Life Outcomes; 2018 Aug; 16(1):160. PubMed ID: 30075729
[TBL] [Abstract][Full Text] [Related]
5. Measuring Health and Broader Well-Being Benefits in the Context of Opiate Dependence: The Psychometric Performance of the ICECAP-A and the EQ-5D-5L.
Goranitis I; Coast J; Day E; Copello A; Freemantle N; Seddon J; Bennett C; Frew E
Value Health; 2016; 19(6):820-828. PubMed ID: 27712710
[TBL] [Abstract][Full Text] [Related]
6. A Validation Study of the EQ-5D-5L and ICEpop Capability Measure for Older People Among Older Individuals With Depressive Symptoms in Brazil.
Nakamura CA; Mitchell PM; Peters TJ; Moreno-Agostino D; Araya R; Scazufca M; Hollingworth W
Value Health Reg Issues; 2022 Jul; 30():91-99. PubMed ID: 35325703
[TBL] [Abstract][Full Text] [Related]
7. Assessing the construct validity and responsiveness of Preference-Based Measures (PBMs) in cataract surgery patients.
Breheny K; Hollingworth W; Kandiyali R; Dixon P; Loose A; Craggs P; Grzeda M; Sparrow J
Qual Life Res; 2020 Jul; 29(7):1935-1946. PubMed ID: 32080789
[TBL] [Abstract][Full Text] [Related]
8. Measuring health-related quality of life and well-being: a head-to-head psychometric comparison of the EQ-5D-5L, ReQoL-UI and ICECAP-A.
Xu RH; Keetharuth AD; Wang LL; Cheung AW; Wong EL
Eur J Health Econ; 2022 Mar; 23(2):165-176. PubMed ID: 34338898
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity to change in well-being and health-related quality of life in adults with eating disorder symptoms: ICECAP-A versus EQ-5D-5L.
van Kaam FE; Rohrbach PJ; van den Akker-Van Marle ME; van Furth EF; Dingemans AE
Int J Eat Disord; 2024 Mar; 57(3):593-601. PubMed ID: 38240329
[TBL] [Abstract][Full Text] [Related]
10. A qualitative investigation of the relevance of skin irritation and self-confidence bolt-ons and their conceptual overlap with the EQ-5D in patients with psoriasis.
Rencz F; Mukuria C; Bató A; Poór AK; Finch AP
Qual Life Res; 2022 Oct; 31(10):3049-3060. PubMed ID: 35471487
[TBL] [Abstract][Full Text] [Related]
11. Content validity of the EQ-5D-5L with skin irritation and self-confidence bolt-ons in patients with atopic dermatitis: a qualitative think-aloud study.
Szlávicz E; Szabó Á; Kinyó Á; Szeiffert A; Bancsók T; Brodszky V; Gyulai R; Rencz F
Qual Life Res; 2024 Jan; 33(1):101-111. PubMed ID: 37787930
[TBL] [Abstract][Full Text] [Related]
12. A qualitative examination of the content validity of the EQ-5D-5L in patients with type 2 diabetes.
Matza LS; Boye KS; Stewart KD; Curtis BH; Reaney M; Landrian AS
Health Qual Life Outcomes; 2015 Dec; 13():192. PubMed ID: 26627874
[TBL] [Abstract][Full Text] [Related]
13. Validity of EQ-5D-5L in stroke.
Golicki D; Niewada M; Buczek J; Karlińska A; Kobayashi A; Janssen MF; Pickard AS
Qual Life Res; 2015 Apr; 24(4):845-50. PubMed ID: 25347978
[TBL] [Abstract][Full Text] [Related]
14. Translation, validity and reliability of the British Sign Language (BSL) version of the EQ-5D-5L.
Rogers KD; Pilling M; Davies L; Belk R; Nassimi-Green C; Young A
Qual Life Res; 2016 Jul; 25(7):1825-34. PubMed ID: 26887955
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in psoriasis.
Yfantopoulos J; Chantzaras A; Kontodimas S
Arch Dermatol Res; 2017 Jul; 309(5):357-370. PubMed ID: 28528371
[TBL] [Abstract][Full Text] [Related]
16. An empirical comparison of the measurement properties of the EQ-5D-5L, DEMQOL-U and DEMQOL-Proxy-U for older people in residential care.
Easton T; Milte R; Crotty M; Ratcliffe J
Qual Life Res; 2018 May; 27(5):1283-1294. PubMed ID: 29305782
[TBL] [Abstract][Full Text] [Related]
17. Validity of EQ-5D-5L health-related quality of life questionnaire in self-reported diabetes: evidence from a general population survey.
Jankowska A; Młyńczak K; Golicki D
Health Qual Life Outcomes; 2021 May; 19(1):138. PubMed ID: 33952271
[TBL] [Abstract][Full Text] [Related]
18. How to measure fluctuating impairments in people with MS: development of an ambulatory assessment version of the EQ-5D-5L in an exploratory study.
Blome C; Carlton J; Heesen C; Janssen MF; Lloyd A; Otten M; Brazier J
Qual Life Res; 2021 Jul; 30(7):2081-2096. PubMed ID: 33710593
[TBL] [Abstract][Full Text] [Related]
19. Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy.
Bhadhuri A; Kind P; Salari P; Jungo KT; Boland B; Byrne S; Hossmann S; Dalleur O; Knol W; Moutzouri E; O'Mahony D; Murphy KD; Wisselink L; Rodondi N; Schwenkglenks M
Health Qual Life Outcomes; 2020 Sep; 18(1):317. PubMed ID: 32993637
[TBL] [Abstract][Full Text] [Related]
20. Psychometric performance assessment of Malay and Malaysian English version of EQ-5D-5L in the Malaysian population.
Shafie AA; Vasan Thakumar A; Lim CJ; Luo N
Qual Life Res; 2019 Jan; 28(1):153-162. PubMed ID: 30317426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
